nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0701	0.121	CbGbCtD
Reboxetine—CYP3A4—Estropipate—osteoporosis	0.0652	0.113	CbGbCtD
Reboxetine—CYP3A4—Calcitriol—osteoporosis	0.0652	0.113	CbGbCtD
Reboxetine—CYP2D6—Cholecalciferol—osteoporosis	0.0528	0.0912	CbGbCtD
Reboxetine—CYP3A4—Ergocalciferol—osteoporosis	0.0521	0.09	CbGbCtD
Reboxetine—ABCB1—Conjugated Estrogens—osteoporosis	0.0515	0.0889	CbGbCtD
Reboxetine—ABCB1—Estradiol—osteoporosis	0.0452	0.078	CbGbCtD
Reboxetine—CYP3A4—Raloxifene—osteoporosis	0.0435	0.0751	CbGbCtD
Reboxetine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.042	0.0725	CbGbCtD
Reboxetine—CYP3A4—Cholecalciferol—osteoporosis	0.0336	0.058	CbGbCtD
Reboxetine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0308	0.0532	CbGbCtD
Reboxetine—CYP3A4—Estradiol—osteoporosis	0.0271	0.0467	CbGbCtD
Reboxetine—Leukopenia—Zoledronate—osteoporosis	0.000425	0.00101	CcSEcCtD
Reboxetine—Infection—Pamidronate—osteoporosis	0.000422	0.001	CcSEcCtD
Reboxetine—Rhinitis—Estradiol—osteoporosis	0.000422	0.001	CcSEcCtD
Reboxetine—Urticaria—Calcitriol—osteoporosis	0.000421	0.001	CcSEcCtD
Reboxetine—Palpitations—Zoledronate—osteoporosis	0.00042	0.000997	CcSEcCtD
Reboxetine—Body temperature increased—Calcitriol—osteoporosis	0.000419	0.000996	CcSEcCtD
Reboxetine—Abdominal pain—Calcitriol—osteoporosis	0.000419	0.000996	CcSEcCtD
Reboxetine—Shock—Pamidronate—osteoporosis	0.000418	0.000992	CcSEcCtD
Reboxetine—Loss of consciousness—Zoledronate—osteoporosis	0.000417	0.000992	CcSEcCtD
Reboxetine—Pharyngitis—Estradiol—osteoporosis	0.000417	0.000992	CcSEcCtD
Reboxetine—Hypersensitivity—Estropipate—osteoporosis	0.000416	0.000989	CcSEcCtD
Reboxetine—Nervous system disorder—Pamidronate—osteoporosis	0.000416	0.000989	CcSEcCtD
Reboxetine—Urinary tract disorder—Estradiol—osteoporosis	0.000415	0.000987	CcSEcCtD
Reboxetine—Vomiting—Etidronic acid—osteoporosis	0.000415	0.000987	CcSEcCtD
Reboxetine—Tachycardia—Pamidronate—osteoporosis	0.000414	0.000984	CcSEcCtD
Reboxetine—Connective tissue disorder—Estradiol—osteoporosis	0.000413	0.000982	CcSEcCtD
Reboxetine—Urethral disorder—Estradiol—osteoporosis	0.000412	0.00098	CcSEcCtD
Reboxetine—Rash—Etidronic acid—osteoporosis	0.000412	0.000978	CcSEcCtD
Reboxetine—Dermatitis—Etidronic acid—osteoporosis	0.000411	0.000977	CcSEcCtD
Reboxetine—Vertigo—Conjugated Estrogens—osteoporosis	0.000411	0.000976	CcSEcCtD
Reboxetine—Hyperhidrosis—Pamidronate—osteoporosis	0.00041	0.000975	CcSEcCtD
Reboxetine—Syncope—Conjugated Estrogens—osteoporosis	0.00041	0.000975	CcSEcCtD
Reboxetine—Hypertension—Zoledronate—osteoporosis	0.00041	0.000975	CcSEcCtD
Reboxetine—Hypersensitivity—Alendronate—osteoporosis	0.00041	0.000974	CcSEcCtD
Reboxetine—Headache—Etidronic acid—osteoporosis	0.000409	0.000972	CcSEcCtD
Reboxetine—Asthenia—Estropipate—osteoporosis	0.000405	0.000963	CcSEcCtD
Reboxetine—Visual impairment—Estradiol—osteoporosis	0.000405	0.000963	CcSEcCtD
Reboxetine—Anorexia—Pamidronate—osteoporosis	0.000405	0.000961	CcSEcCtD
Reboxetine—Chest pain—Zoledronate—osteoporosis	0.000404	0.000961	CcSEcCtD
Reboxetine—Palpitations—Conjugated Estrogens—osteoporosis	0.000404	0.00096	CcSEcCtD
Reboxetine—Insomnia—Risedronate—osteoporosis	0.000404	0.00096	CcSEcCtD
Reboxetine—Anxiety—Zoledronate—osteoporosis	0.000403	0.000958	CcSEcCtD
Reboxetine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000402	0.000955	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000402	0.000954	CcSEcCtD
Reboxetine—Paraesthesia—Risedronate—osteoporosis	0.000401	0.000953	CcSEcCtD
Reboxetine—Discomfort—Zoledronate—osteoporosis	0.0004	0.000949	CcSEcCtD
Reboxetine—Asthenia—Alendronate—osteoporosis	0.000399	0.000949	CcSEcCtD
Reboxetine—Hypersensitivity—Ibandronate—osteoporosis	0.000399	0.000948	CcSEcCtD
Reboxetine—Dyspnoea—Risedronate—osteoporosis	0.000398	0.000946	CcSEcCtD
Reboxetine—Hypotension—Pamidronate—osteoporosis	0.000397	0.000942	CcSEcCtD
Reboxetine—Dry mouth—Zoledronate—osteoporosis	0.000395	0.00094	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000395	0.000939	CcSEcCtD
Reboxetine—Dyspepsia—Risedronate—osteoporosis	0.000393	0.000934	CcSEcCtD
Reboxetine—Eye disorder—Estradiol—osteoporosis	0.000393	0.000934	CcSEcCtD
Reboxetine—Tinnitus—Estradiol—osteoporosis	0.000392	0.000932	CcSEcCtD
Reboxetine—Constipation—Ethinyl Estradiol—osteoporosis	0.000392	0.000931	CcSEcCtD
Reboxetine—Confusional state—Zoledronate—osteoporosis	0.000391	0.000929	CcSEcCtD
Reboxetine—Hypersensitivity—Calcitriol—osteoporosis	0.000391	0.000928	CcSEcCtD
Reboxetine—Cardiac disorder—Estradiol—osteoporosis	0.00039	0.000927	CcSEcCtD
Reboxetine—Chest pain—Conjugated Estrogens—osteoporosis	0.000389	0.000925	CcSEcCtD
Reboxetine—Asthenia—Ibandronate—osteoporosis	0.000389	0.000924	CcSEcCtD
Reboxetine—Anxiety—Conjugated Estrogens—osteoporosis	0.000388	0.000922	CcSEcCtD
Reboxetine—Nausea—Etidronic acid—osteoporosis	0.000388	0.000922	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000387	0.000919	CcSEcCtD
Reboxetine—Diarrhoea—Estropipate—osteoporosis	0.000387	0.000919	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000385	0.000916	CcSEcCtD
Reboxetine—Infection—Zoledronate—osteoporosis	0.000385	0.000915	CcSEcCtD
Reboxetine—Insomnia—Pamidronate—osteoporosis	0.000384	0.000912	CcSEcCtD
Reboxetine—Constipation—Risedronate—osteoporosis	0.000382	0.000907	CcSEcCtD
Reboxetine—Angiopathy—Estradiol—osteoporosis	0.000382	0.000907	CcSEcCtD
Reboxetine—Shock—Zoledronate—osteoporosis	0.000381	0.000906	CcSEcCtD
Reboxetine—Paraesthesia—Pamidronate—osteoporosis	0.000381	0.000906	CcSEcCtD
Reboxetine—Diarrhoea—Alendronate—osteoporosis	0.000381	0.000905	CcSEcCtD
Reboxetine—Asthenia—Calcitriol—osteoporosis	0.00038	0.000904	CcSEcCtD
Reboxetine—Nervous system disorder—Zoledronate—osteoporosis	0.00038	0.000903	CcSEcCtD
Reboxetine—Immune system disorder—Estradiol—osteoporosis	0.00038	0.000903	CcSEcCtD
Reboxetine—Mediastinal disorder—Estradiol—osteoporosis	0.000379	0.000901	CcSEcCtD
Reboxetine—Dyspnoea—Pamidronate—osteoporosis	0.000378	0.000899	CcSEcCtD
Reboxetine—Tachycardia—Zoledronate—osteoporosis	0.000378	0.000899	CcSEcCtD
Reboxetine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000377	0.000897	CcSEcCtD
Reboxetine—Chills—Estradiol—osteoporosis	0.000377	0.000897	CcSEcCtD
Reboxetine—Somnolence—Pamidronate—osteoporosis	0.000377	0.000897	CcSEcCtD
Reboxetine—Skin disorder—Zoledronate—osteoporosis	0.000377	0.000895	CcSEcCtD
Reboxetine—Hyperhidrosis—Zoledronate—osteoporosis	0.000375	0.000891	CcSEcCtD
Reboxetine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000374	0.00089	CcSEcCtD
Reboxetine—Diarrhoea—Raloxifene—osteoporosis	0.000374	0.00089	CcSEcCtD
Reboxetine—Dyspepsia—Pamidronate—osteoporosis	0.000374	0.000888	CcSEcCtD
Reboxetine—Dizziness—Estropipate—osteoporosis	0.000374	0.000888	CcSEcCtD
Reboxetine—Infection—Conjugated Estrogens—osteoporosis	0.000371	0.000881	CcSEcCtD
Reboxetine—Diarrhoea—Ibandronate—osteoporosis	0.000371	0.000881	CcSEcCtD
Reboxetine—Anorexia—Zoledronate—osteoporosis	0.00037	0.000878	CcSEcCtD
Reboxetine—Decreased appetite—Pamidronate—osteoporosis	0.000369	0.000877	CcSEcCtD
Reboxetine—Mental disorder—Estradiol—osteoporosis	0.000368	0.000875	CcSEcCtD
Reboxetine—Dizziness—Alendronate—osteoporosis	0.000368	0.000874	CcSEcCtD
Reboxetine—Shock—Conjugated Estrogens—osteoporosis	0.000367	0.000873	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000366	0.000871	CcSEcCtD
Reboxetine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000366	0.00087	CcSEcCtD
Reboxetine—Malnutrition—Estradiol—osteoporosis	0.000366	0.00087	CcSEcCtD
Reboxetine—Gastrointestinal pain—Risedronate—osteoporosis	0.000365	0.000868	CcSEcCtD
Reboxetine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000364	0.000866	CcSEcCtD
Reboxetine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000364	0.000864	CcSEcCtD
Reboxetine—Constipation—Pamidronate—osteoporosis	0.000363	0.000862	CcSEcCtD
Reboxetine—Diarrhoea—Calcitriol—osteoporosis	0.000363	0.000862	CcSEcCtD
Reboxetine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000363	0.000862	CcSEcCtD
Reboxetine—Hypotension—Zoledronate—osteoporosis	0.000362	0.000861	CcSEcCtD
Reboxetine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000362	0.00086	CcSEcCtD
Reboxetine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000362	0.00086	CcSEcCtD
Reboxetine—Dizziness—Raloxifene—osteoporosis	0.000362	0.00086	CcSEcCtD
Reboxetine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000361	0.000858	CcSEcCtD
Reboxetine—Tension—Estradiol—osteoporosis	0.000359	0.000854	CcSEcCtD
Reboxetine—Vomiting—Estropipate—osteoporosis	0.000359	0.000854	CcSEcCtD
Reboxetine—Dysgeusia—Estradiol—osteoporosis	0.000358	0.000852	CcSEcCtD
Reboxetine—Dizziness—Ibandronate—osteoporosis	0.000358	0.000851	CcSEcCtD
Reboxetine—Rash—Estropipate—osteoporosis	0.000356	0.000846	CcSEcCtD
Reboxetine—Dermatitis—Estropipate—osteoporosis	0.000356	0.000846	CcSEcCtD
Reboxetine—Anorexia—Conjugated Estrogens—osteoporosis	0.000356	0.000846	CcSEcCtD
Reboxetine—Nervousness—Estradiol—osteoporosis	0.000356	0.000845	CcSEcCtD
Reboxetine—Urticaria—Risedronate—osteoporosis	0.000355	0.000843	CcSEcCtD
Reboxetine—Headache—Estropipate—osteoporosis	0.000354	0.000841	CcSEcCtD
Reboxetine—Vomiting—Alendronate—osteoporosis	0.000354	0.000841	CcSEcCtD
Reboxetine—Abdominal pain—Risedronate—osteoporosis	0.000353	0.000839	CcSEcCtD
Reboxetine—Body temperature increased—Risedronate—osteoporosis	0.000353	0.000839	CcSEcCtD
Reboxetine—Rash—Alendronate—osteoporosis	0.000351	0.000834	CcSEcCtD
Reboxetine—Insomnia—Zoledronate—osteoporosis	0.000351	0.000833	CcSEcCtD
Reboxetine—Dermatitis—Alendronate—osteoporosis	0.00035	0.000833	CcSEcCtD
Reboxetine—Feeling abnormal—Pamidronate—osteoporosis	0.00035	0.000831	CcSEcCtD
Reboxetine—Hypotension—Conjugated Estrogens—osteoporosis	0.000349	0.000829	CcSEcCtD
Reboxetine—Headache—Alendronate—osteoporosis	0.000349	0.000828	CcSEcCtD
Reboxetine—Paraesthesia—Zoledronate—osteoporosis	0.000348	0.000827	CcSEcCtD
Reboxetine—Vomiting—Raloxifene—osteoporosis	0.000348	0.000827	CcSEcCtD
Reboxetine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000347	0.000825	CcSEcCtD
Reboxetine—Dyspnoea—Zoledronate—osteoporosis	0.000346	0.000821	CcSEcCtD
Reboxetine—Rash—Raloxifene—osteoporosis	0.000345	0.00082	CcSEcCtD
Reboxetine—Dermatitis—Raloxifene—osteoporosis	0.000345	0.000819	CcSEcCtD
Reboxetine—Somnolence—Zoledronate—osteoporosis	0.000345	0.000819	CcSEcCtD
Reboxetine—Vomiting—Ibandronate—osteoporosis	0.000344	0.000819	CcSEcCtD
Reboxetine—Tremor—Estradiol—osteoporosis	0.000343	0.000815	CcSEcCtD
Reboxetine—Headache—Raloxifene—osteoporosis	0.000343	0.000815	CcSEcCtD
Reboxetine—Rash—Ibandronate—osteoporosis	0.000342	0.000812	CcSEcCtD
Reboxetine—Dermatitis—Ibandronate—osteoporosis	0.000341	0.000811	CcSEcCtD
Reboxetine—Dyspepsia—Zoledronate—osteoporosis	0.000341	0.000811	CcSEcCtD
Reboxetine—Ill-defined disorder—Estradiol—osteoporosis	0.00034	0.000807	CcSEcCtD
Reboxetine—Headache—Ibandronate—osteoporosis	0.000339	0.000806	CcSEcCtD
Reboxetine—Insomnia—Conjugated Estrogens—osteoporosis	0.000338	0.000802	CcSEcCtD
Reboxetine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000337	0.000802	CcSEcCtD
Reboxetine—Vomiting—Calcitriol—osteoporosis	0.000337	0.000801	CcSEcCtD
Reboxetine—Decreased appetite—Zoledronate—osteoporosis	0.000337	0.000801	CcSEcCtD
Reboxetine—Agitation—Estradiol—osteoporosis	0.000336	0.000799	CcSEcCtD
Reboxetine—Nausea—Estropipate—osteoporosis	0.000336	0.000797	CcSEcCtD
Reboxetine—Abdominal pain—Pamidronate—osteoporosis	0.000335	0.000797	CcSEcCtD
Reboxetine—Body temperature increased—Pamidronate—osteoporosis	0.000335	0.000797	CcSEcCtD
Reboxetine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000335	0.000797	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000335	0.000795	CcSEcCtD
Reboxetine—Rash—Calcitriol—osteoporosis	0.000334	0.000795	CcSEcCtD
Reboxetine—Dermatitis—Calcitriol—osteoporosis	0.000334	0.000794	CcSEcCtD
Reboxetine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000333	0.000791	CcSEcCtD
Reboxetine—Headache—Calcitriol—osteoporosis	0.000332	0.000789	CcSEcCtD
Reboxetine—Somnolence—Conjugated Estrogens—osteoporosis	0.000332	0.000789	CcSEcCtD
Reboxetine—Constipation—Zoledronate—osteoporosis	0.000331	0.000788	CcSEcCtD
Reboxetine—Nausea—Alendronate—osteoporosis	0.00033	0.000785	CcSEcCtD
Reboxetine—Malaise—Estradiol—osteoporosis	0.00033	0.000784	CcSEcCtD
Reboxetine—Hypersensitivity—Risedronate—osteoporosis	0.000329	0.000782	CcSEcCtD
Reboxetine—Vertigo—Estradiol—osteoporosis	0.000329	0.000782	CcSEcCtD
Reboxetine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000329	0.000781	CcSEcCtD
Reboxetine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000329	0.000781	CcSEcCtD
Reboxetine—Syncope—Estradiol—osteoporosis	0.000328	0.00078	CcSEcCtD
Reboxetine—Nausea—Raloxifene—osteoporosis	0.000325	0.000772	CcSEcCtD
Reboxetine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000324	0.000771	CcSEcCtD
Reboxetine—Palpitations—Estradiol—osteoporosis	0.000323	0.000769	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000322	0.000766	CcSEcCtD
Reboxetine—Nausea—Ibandronate—osteoporosis	0.000322	0.000765	CcSEcCtD
Reboxetine—Loss of consciousness—Estradiol—osteoporosis	0.000322	0.000765	CcSEcCtD
Reboxetine—Asthenia—Risedronate—osteoporosis	0.00032	0.000761	CcSEcCtD
Reboxetine—Feeling abnormal—Zoledronate—osteoporosis	0.000319	0.000759	CcSEcCtD
Reboxetine—Constipation—Conjugated Estrogens—osteoporosis	0.000319	0.000759	CcSEcCtD
Reboxetine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000317	0.000753	CcSEcCtD
Reboxetine—Hypertension—Estradiol—osteoporosis	0.000316	0.000751	CcSEcCtD
Reboxetine—Nausea—Calcitriol—osteoporosis	0.000315	0.000749	CcSEcCtD
Reboxetine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000313	0.000745	CcSEcCtD
Reboxetine—Hypersensitivity—Pamidronate—osteoporosis	0.000313	0.000743	CcSEcCtD
Reboxetine—Chest pain—Estradiol—osteoporosis	0.000312	0.000741	CcSEcCtD
Reboxetine—Anxiety—Estradiol—osteoporosis	0.000311	0.000738	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000309	0.000735	CcSEcCtD
Reboxetine—Urticaria—Zoledronate—osteoporosis	0.000308	0.000732	CcSEcCtD
Reboxetine—Discomfort—Estradiol—osteoporosis	0.000308	0.000732	CcSEcCtD
Reboxetine—Abdominal pain—Zoledronate—osteoporosis	0.000306	0.000728	CcSEcCtD
Reboxetine—Body temperature increased—Zoledronate—osteoporosis	0.000306	0.000728	CcSEcCtD
Reboxetine—Diarrhoea—Risedronate—osteoporosis	0.000305	0.000726	CcSEcCtD
Reboxetine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000305	0.000725	CcSEcCtD
Reboxetine—Dry mouth—Estradiol—osteoporosis	0.000305	0.000724	CcSEcCtD
Reboxetine—Asthenia—Pamidronate—osteoporosis	0.000304	0.000724	CcSEcCtD
Reboxetine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000303	0.00072	CcSEcCtD
Reboxetine—Confusional state—Estradiol—osteoporosis	0.000301	0.000716	CcSEcCtD
Reboxetine—Infection—Estradiol—osteoporosis	0.000297	0.000705	CcSEcCtD
Reboxetine—Urticaria—Conjugated Estrogens—osteoporosis	0.000297	0.000705	CcSEcCtD
Reboxetine—Dizziness—Risedronate—osteoporosis	0.000295	0.000702	CcSEcCtD
Reboxetine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000295	0.000701	CcSEcCtD
Reboxetine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000295	0.000701	CcSEcCtD
Reboxetine—Shock—Estradiol—osteoporosis	0.000294	0.000698	CcSEcCtD
Reboxetine—Nervous system disorder—Estradiol—osteoporosis	0.000293	0.000696	CcSEcCtD
Reboxetine—Tachycardia—Estradiol—osteoporosis	0.000292	0.000693	CcSEcCtD
Reboxetine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000291	0.000692	CcSEcCtD
Reboxetine—Diarrhoea—Pamidronate—osteoporosis	0.00029	0.00069	CcSEcCtD
Reboxetine—Skin disorder—Estradiol—osteoporosis	0.00029	0.00069	CcSEcCtD
Reboxetine—Hyperhidrosis—Estradiol—osteoporosis	0.000289	0.000686	CcSEcCtD
Reboxetine—Rash—Ethinyl Estradiol—osteoporosis	0.000289	0.000686	CcSEcCtD
Reboxetine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000288	0.000685	CcSEcCtD
Reboxetine—Headache—Ethinyl Estradiol—osteoporosis	0.000287	0.000682	CcSEcCtD
Reboxetine—Hypersensitivity—Zoledronate—osteoporosis	0.000286	0.000679	CcSEcCtD
Reboxetine—Vomiting—Risedronate—osteoporosis	0.000284	0.000675	CcSEcCtD
Reboxetine—Rash—Risedronate—osteoporosis	0.000281	0.000669	CcSEcCtD
Reboxetine—Dermatitis—Risedronate—osteoporosis	0.000281	0.000668	CcSEcCtD
Reboxetine—Dizziness—Pamidronate—osteoporosis	0.000281	0.000667	CcSEcCtD
Reboxetine—Headache—Risedronate—osteoporosis	0.00028	0.000665	CcSEcCtD
Reboxetine—Asthenia—Zoledronate—osteoporosis	0.000278	0.000661	CcSEcCtD
Reboxetine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000275	0.000654	CcSEcCtD
Reboxetine—Nausea—Ethinyl Estradiol—osteoporosis	0.000272	0.000646	CcSEcCtD
Reboxetine—Insomnia—Estradiol—osteoporosis	0.00027	0.000642	CcSEcCtD
Reboxetine—Vomiting—Pamidronate—osteoporosis	0.00027	0.000641	CcSEcCtD
Reboxetine—Paraesthesia—Estradiol—osteoporosis	0.000268	0.000637	CcSEcCtD
Reboxetine—Asthenia—Conjugated Estrogens—osteoporosis	0.000268	0.000636	CcSEcCtD
Reboxetine—Rash—Pamidronate—osteoporosis	0.000268	0.000636	CcSEcCtD
Reboxetine—Dermatitis—Pamidronate—osteoporosis	0.000267	0.000635	CcSEcCtD
Reboxetine—Dyspnoea—Estradiol—osteoporosis	0.000266	0.000633	CcSEcCtD
Reboxetine—Headache—Pamidronate—osteoporosis	0.000266	0.000632	CcSEcCtD
Reboxetine—Somnolence—Estradiol—osteoporosis	0.000266	0.000631	CcSEcCtD
Reboxetine—Diarrhoea—Zoledronate—osteoporosis	0.000265	0.00063	CcSEcCtD
Reboxetine—Nausea—Risedronate—osteoporosis	0.000265	0.00063	CcSEcCtD
Reboxetine—Dyspepsia—Estradiol—osteoporosis	0.000263	0.000625	CcSEcCtD
Reboxetine—Decreased appetite—Estradiol—osteoporosis	0.00026	0.000617	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000258	0.000613	CcSEcCtD
Reboxetine—Dizziness—Zoledronate—osteoporosis	0.000256	0.000609	CcSEcCtD
Reboxetine—Constipation—Estradiol—osteoporosis	0.000255	0.000607	CcSEcCtD
Reboxetine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000255	0.000607	CcSEcCtD
Reboxetine—Nausea—Pamidronate—osteoporosis	0.000252	0.000599	CcSEcCtD
Reboxetine—Dizziness—Conjugated Estrogens—osteoporosis	0.000247	0.000587	CcSEcCtD
Reboxetine—Vomiting—Zoledronate—osteoporosis	0.000246	0.000586	CcSEcCtD
Reboxetine—Feeling abnormal—Estradiol—osteoporosis	0.000246	0.000585	CcSEcCtD
Reboxetine—Rash—Zoledronate—osteoporosis	0.000244	0.000581	CcSEcCtD
Reboxetine—Gastrointestinal pain—Estradiol—osteoporosis	0.000244	0.000581	CcSEcCtD
Reboxetine—Dermatitis—Zoledronate—osteoporosis	0.000244	0.00058	CcSEcCtD
Reboxetine—Headache—Zoledronate—osteoporosis	0.000243	0.000577	CcSEcCtD
Reboxetine—Vomiting—Conjugated Estrogens—osteoporosis	0.000237	0.000564	CcSEcCtD
Reboxetine—Urticaria—Estradiol—osteoporosis	0.000237	0.000564	CcSEcCtD
Reboxetine—Abdominal pain—Estradiol—osteoporosis	0.000236	0.000561	CcSEcCtD
Reboxetine—Body temperature increased—Estradiol—osteoporosis	0.000236	0.000561	CcSEcCtD
Reboxetine—Rash—Conjugated Estrogens—osteoporosis	0.000235	0.000559	CcSEcCtD
Reboxetine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000235	0.000559	CcSEcCtD
Reboxetine—Headache—Conjugated Estrogens—osteoporosis	0.000234	0.000556	CcSEcCtD
Reboxetine—Nausea—Zoledronate—osteoporosis	0.00023	0.000547	CcSEcCtD
Reboxetine—Nausea—Conjugated Estrogens—osteoporosis	0.000222	0.000527	CcSEcCtD
Reboxetine—Hypersensitivity—Estradiol—osteoporosis	0.00022	0.000523	CcSEcCtD
Reboxetine—Asthenia—Estradiol—osteoporosis	0.000214	0.000509	CcSEcCtD
Reboxetine—Diarrhoea—Estradiol—osteoporosis	0.000204	0.000486	CcSEcCtD
Reboxetine—Dizziness—Estradiol—osteoporosis	0.000198	0.000469	CcSEcCtD
Reboxetine—Vomiting—Estradiol—osteoporosis	0.00019	0.000451	CcSEcCtD
Reboxetine—Rash—Estradiol—osteoporosis	0.000188	0.000448	CcSEcCtD
Reboxetine—Dermatitis—Estradiol—osteoporosis	0.000188	0.000447	CcSEcCtD
Reboxetine—Headache—Estradiol—osteoporosis	0.000187	0.000445	CcSEcCtD
Reboxetine—Nausea—Estradiol—osteoporosis	0.000177	0.000422	CcSEcCtD
